Brief: Appili Therapeutics Reports Q1 Loss Per Share $0.06
21/08/2019 22:09
Aug 21 (Reuters) - Appili Therapeutics Inc APLI.V :
* APPILI THERAPEUTICS REPORTS FINANCIAL RESULTS FOR FIRST
QUARTER
OF FISCAL YEAR 2020
* APPILI THERAPEUTICS INC - NET LOSS AND COMPREHENSIVE LOSS
OF
$1,799,012 OR $0.06 LOSS PER SHARE FOR QUARTER ENDED JUNE 30,
2019
Source text for Eikon: ID:nBwlzTSRa
Further company coverage: APLI.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Appili Therapeutics
See all newsBrief: Appili Therapeutics Announces Closing Of Second Tranche Of Non-Brokered Private Placement
Brief: Appili Therapeutics Closes First Tranche Of Non-Brokered Private Placement
Brief: Appili Therapeutics Announces Proposed Non-Brokered Private Placement
Brief: Appili Therapeutics Announces Formal Termination Of Arrangement Agreement With Aditxt
Brief: Appili Therapeutics Announces New Patents Granted For Commercial Stage Asset Likmez